MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/infdis/jiz592

Медицинская библиотека · The Journal of infectious diseases · 2020

The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States.

Glass Aaron, Polhemus Mark, Wang Dongliang, Jarman Richard G, Thomas Stephen J, Friberg Heather, Currier Jeffrey R, Bonaparte Matthew, De La Barra Rafael, Princiotta Michael F, Abbott Mark, Cuzzo Brian, Machabert Tifany, Sridhar Saranya, Endy Timothy P

Клиническое исследование II фазыСтатьяРандомизированное исследованиеПоддержка правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Dengue is a global health problem requiring an effective, safe dengue vaccine.

METHODS

We report the results of a phase II, randomized, open-label, single-center trial in adults aged 18 to 45 years in the United States designed to explore the effects of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine (CYD-TDV, Dengvaxia) when administered on its designated schedule (months 0, 6, and 12) or on an accelerated dosing schedule (months 0, 2, and 6) and/or given before, or concomitantly with, a vaccine against Japanese encephalitis (JE).

RESULTS

Based on dengue virus serotype-specific neutralizing antibody (NAb), the accelerated dosing schedule was comparable to the 0, 6, and 12-month schedule. Giving JE vaccine concurrently with CYD-TDV did not result in an increase in overall NAb titers. Immunophenotyping of peripheral blood mononuclear cells revealed an increase in activated CD8+ T cells after CYD-TDV vaccination, a phenomenon that was greatest for the JE vaccine primed.

CONCLUSIONS

We conclude that an accelerated dosing schedule of CYD-TDV results in essentially equivalent dengue serotype-specific NAb titers as the currently used schedule, and there may be an early benefit in antibody titers and activated CD8+ T cells by the administration of the JE vaccine before CYD-TDV vaccination.

Для цитирования: Glass Aaron, Polhemus Mark, Wang Dongliang, Jarman Richard G, Thomas Stephen J, Friberg Heather, Currier Jeffrey R, Bonaparte Matthew, De La Barra Rafael, Princiotta Michael F, Abbott Mark, Cuzzo Brian, Machabert Tifany, Sridhar Saranya, Endy Timothy P. The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States.. The Journal of infectious diseases. 2020. DOI: 10.1093/infdis/jiz592.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.